HLA-E: Presentation of a Broader Peptide Repertoire Impacts the Cellular Immune Response—Implications on HSCT Outcome

HLA-E polymorphism and clinical outcome after allogeneic hematopoietic stem cell transplantation in Egyptian patients

(2015) Ghada I. Mossallam et al.   HUMAN IMMUNOLOGY

IL-12–producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion

(2014) Alexander Rölle et al.   JOURNAL OF CLINICAL INVESTIGATION

WorldwideHLA-Enucleotide and haplotype variability reveals a conserved gene for coding and 3′ untranslated regions

(2014) L. P. Felício et al.   TISSUE ANTIGENS

HLA-E: A Novel Player for Histocompatibility

(2014) Thomas Kraemer et al.   Journal of Immunology Research

Soluble HLA Technology as a Strategy to Evaluate the Impact of HLA Mismatches

(2014) Heike Kunze-Schumacher et al.   Journal of Immunology Research

Polymorphism in Human Cytomegalovirus UL40 Impacts on Recognition of Human Leukocyte Antigen-E (HLA-E) by Natural Killer Cells

(2013) Susan L. Heatley et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT

(2012) E. H. Warren et al.   BLOOD

Residue 81 confers a restricted C-terminal peptide binding motif in HLA-B*44:09

(2012) Trevor Huyton et al.   IMMUNOGENETICS

Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2

(2012) Margit H. Lampen et al.   MOLECULAR IMMUNOLOGY

HLA-E-Restricted Cross-Recognition of Allogeneic Endothelial Cells by CMV-Associated CD8 T Cells: A Potential Risk Factor following Transplantation

(2012) Mathilde Allard et al.   PLoS One

Pocketcheck: updating the HLA class I peptide specificity roadmap

(2012) T. Huyton et al.   TISSUE ANTIGENS

Position 156 influences the peptide repertoire and tapasin dependency of human leukocyte antigen B*44 allotypes

(2011) S. Badrinath et al.   HAEMATOLOGICA

Mismatches outside exons 2 and 3 do not alter the peptide motif of the allele group B*44:02P

(2011) Christina Bade-Doeding et al.   HUMAN IMMUNOLOGY

Position 45 influences the peptide binding motif of HLA-B*44:08

(2011) Soumya Badrinath et al.   IMMUNOGENETICS

The composition of the F pocket in HLA-A*74 generates C-terminal promiscuity among its bound peptides

(2011) C. Bade-Doeding et al.   TISSUE ANTIGENS

Features and development ofCoot

(2010) P. Emsley et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family

(2010) C. Bade-Doding et al.   HAEMATOLOGICA

Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus

(2010) Niklas K. Björkström et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Polymorphism between HLA-A*0301 and A*0302 located outside the pocket F alters the PΩ peptide motif

(2010) N. E. Elamin et al.   TISSUE ANTIGENS

Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity

(2008) D. Pende et al.   BLOOD

CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence

(2008) Emma J. Petrie et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Subtle Changes in Peptide Conformation Profoundly Affect Recognition of the Non-Classical MHC Class I Molecule HLA-E by the CD94–NKG2 Natural Killer Cell Receptors

(2008) Hilary L. Hoare et al.   JOURNAL OF MOLECULAR BIOLOGY

Up on the tightrope: natural killer cell activation and inhibition

(2008) Lewis L Lanier   NATURE IMMUNOLOGY

Structural basis for NKG2A/CD94 recognition of HLA-E

(2008) B. K. Kaiser et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity

(2008) L. C. Sullivan et al.   TISSUE ANTIGENS